BLKR201 A Phase 1 central-nervous-system-penetrant TYK2 inhibitor being developed for inflammatory diseases.
Visit productCosigns Received
Be the first Cosign
Put your name behind BLKR201.
Add it to your Products I use list and share why you use it.